New findings and treatment strategies for hypoglycemia and hypoglycemia unawareness

Current Opinion in Endocrinology and Diabetes

Volumn 5, Issue 2, 1998, Pages 136-143

  McCall, Anthony L ^a  

^a PORTLAND VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; INSULIN;

DISEASE PREDISPOSITION; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; NERVOUS SYSTEM; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOGENESIS; PATHOPHYSIOLOGY; REVIEW;

EID: 0031776183     PISSN: 10683097     EISSN: None     Source Type: Journal    
DOI: 10.1097/00060793-199804000-00009     Document Type: Review

References (73)

1. Cryer PE, Gerich JE: Hypoglycemia in insulin-dependent diabetes mellitus: interplay of insulin excess and compromised glucose counter-regulation. In Diabetes Mellitus, edn 5. Edited by Porte D Jr, Sherwin RS. Stamford: Appleton & Lange; 1997:745-760.
2. Cryer PE: Hierarchy of physiological responses to hypoglycemia: relevance to clinical hypoglycemia in type 1 (insulin dependent) diabetes mellitus. Horm Metab Res 1997, 29:92-96. Excellent review of hypoglycemia in diabetes.
3. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993, 329:977-986.
4. The Diabetes Control and Complications Trial Research Group: Hypoglycemia in the Diabetes Control and Complications Trial: the Diabetes Control and Complications Trial Research Group. Diabetes 1997, 46:271-286. The most detailed analysis of hypoglycemia in the largest study of diabetes control and complications.
5. Reichard P, Nilsson BY, Rosenqvist U: The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N Engl J Med 1993, 329:304-309.
6. Reichard P, Pihl M: Mortality and treatment side-effects during long-term intensified conventional insulin treatment in the Stockholm Diabetes Intervention Study. Diabetes 1994, 43:313-317.
7. Perros P, Deary IJ, Sellar RJ, Best JJ, Frier BM: Brain abnormalities demonstrated by magnetic resonance imaging in adult IDDM patients with and without a history of recurrent severe hypoglycemia. Diabetes Care 1997, 20:1013-1018.
8. Gold AE, MacLeod KM, Deary IJ, Frier BM: Hypoglycemia-induced cognitive dysfunction in diabetes mellitus: effect of hypoglycemia unawareness. Physiol Behav 1995, 58:501-511.
9. Deary IJ, Crawford JR, Hepburn DA, Langan SJ, Blackmore LM, Frier BM: Severe hypoglycemia and intelligence in adult patients with insulin-treated diabetes. Diabetes 1993, 42:341-344.
10. Bjorgaas M, Sand T, Grimse R: Quantitative EEG in type 1 diabetic children with and without episodes of severe hypoglycemia: a controlled, blind study. Acta Neurol Scand 1996, 93:398-402.
11. Fujioka M, Okuchi K, Hiramatsu KI, Sakaki T, Sakaguchi S, Ishii Y: Specific changes in human brain after hypoglycemic injury. Stroke 1997, 28:584-587.
12. Marques JL, George E, Peacey SR, Harris ND, Macdonald IA, Cochrane T, Heller SR: Altered ventricular repolarizatlon during hypoglycaemia in patients with diabetes. Diabet Med 1997, 14:648-654.
13. Ohkubo Y, Kishikawa H, Araki E, Miyata T, Isammi S, Motoyoshi S, Kojima Y, Furuyoshi N, Shichiri M: Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract 1995, 28:103-117.
14. Matyka K, Evans M, Lomas J, Cranston I, Macdonald I, Amiel SA: Altered hierarchy of protective responses against severe hypoglycemia in normal aging in healthy men. Diabetes Care 1997, 20:135-141.
15. Van Staa T, Abenhaim L, Monette J: Rates of hypoglycemic in users of sulfonylureas. J Clin Epidemiol 1997, 50:735-741.
16. Shorr RI, Ray WA, Daugherty JR, Griffin MR: Incidence and risk factors for serious hypoglycemic in older persons using insulin or sulfonylureas. Arch Intern Med 1997, 157:1681-1686.
17. Veneman TF, Erkelens DW: Clinical review: hypoglycemia unawareness in noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1997, 82:1682-1684.
18. Bolli GB, Tsalikian E, Haymond MW, Cryer PE, Gerich JE: Defective glucose counterregulation after subcutaneous insulin in noninsulin-dependent diabetes mellitus: paradoxical suppression of glucose utilization and lack of compensatory increase in glucose production, roles of insulin resistance, abnormal neuroendocrine responses, and islet paracrine interactions. J Clin Invest 1984, 73:1532-1541.
19. Shamoon H, Friedman S, Canton C, Zacharowicz L, Hu M, Rossetti L: Increased epinephrine and skeletal muscle responses to hypoglycemia in non-insulin-dependent diabetes mellitus. J Clin Invest 1994, 93:2562-2571.
20. Ohno T, Toyama T, Hoshizaki H, Okamoto E, Naito S, Nogami A, Kamiyama H, Ohshima S, Yuasa K, Taniguchi K, et al.: Evaluation of cardiac sympathetic nervous function by 123I-metaiodobenzylguanidine scintigraphy in insulin-treated non-insulin dependent diabetics with hypoglycemia unawareness. Intern Med 1996, 35:94-99.
21. Davis SN, Shavers C, Davis B, Costa F: Prevention of an increase in plasma cortisol during hypoglycemia preserves subsequent counter-regulatory responses. J Clin Invest 1997, 100:429-438.
22. Davis SN, Shavers C, Costa F, Mosqueda-Garcia R: Role of cortisol in the pathogenesis of deficient counterregulation after antecedent hypoglycemia in normal humans. J Clin Invest 1996, 98:680-691. Perhaps the most important new insight in the genesis of defective hypoglycemia counterregulation in recent years.
23. Pampanelli S, Lalli C, Del Sindaco P, Lepore M, Ciofetta M, Fanelli C, Brunetti P, Bolli GB: Effect of recent, antecedent hypoglycemia and response of cortisol per se, on responses to subsequent hypoglycemia in humans [abstract]. Diabetologia 1997, 40:A27.
24. Pacak K, Palkovits M, Kvetnansky R, Matern P, Hart C, Kopin IJ, Goldstein DS: Catecholaminergic inhibition by hypercortisolemia in the paraventricular nucleus of conscious rats. Endocrinology 1995, 136:4814-4819.
25. Brown MR, Gray TS, Fisher LA: Corticotropin-releasing factor receptor antagonist: effects on the autonomic nervous system and cardiovascular function. Regul Pept 1986, 16:321-329.
26. Chipkin SR, Van Bueren A, Bercel E, McCall AL: Effects of dexamethasone in vivo and in vitro on glucose transport in brain microvasculature. Neurochem Res 1998, 23:649-656.
27. Pelligrino DA, Segil LJ, Albrecht RF: Brain glucose utilization and transport and cortical function in chronic vs. acute hypoglycemia. Am J Physiol 1990, 259:E729-E735.
28. McCall AL, Fixman LB, Fleming N, Tornheim K, Chick W, Ruderman NB: Chronic hypoglycemia increases brain glucose transport. Am J Physiol 1986, 251:E442-E447.
29. Boyle PJ, Kempers SF, O'Connor AM, Nagy RJ: Brain glucose uptake and unawareness of hypoglycemia in patients with insulin-dependent diabetes mellitus. N Engl J Med 1995, 333:1726-1731.
30. Boyle PJ, Nagy RJ, O'Connor AM, Kempers SF, Yeo RA, Qualls C: Adaptation in brain glucose uptake following recurrent hypoglycemia. Proc Natl Acad Sci U S A 1994, 91:9352-9356.
31. Figlewicz DP, Brot MD, McCall AL, Szot P: Differential gene regulation of CNS noradrenergic and dopaminergic neurons by diabetes. Brain Res 1996, 736:54-60.
32. Figlewicz DP, Bentson K, Ocrant I: The effect of insulin on norepinephrine uptake by PC12 cells. Brain Res Bull 1993, 32:425-431.
33. Figlewicz DP, Szot P, Israel PA, Payne C, Dorsa DM: Insulin reduces norepinephrine transporter mRNA in vivo in rat locus coeruleus. Brain Res 1993, 602:161-164.
34. Baura GD, Foster DM, Kaiyala K, Porte D Jr, Kahn SE, Schwartz MW: Insulin transport from plasma into the central nervous system is inhibited by dexamethasone in dogs. Diabetes 1996, 45:86-90.
35. Lingenfelser T, Overkamp D, Renn W, Buettner U, Kimmerle K, Schmalfuss A, Jakober B: Insulin-associated modulation of neuroendocrine counterregulation, hypoglycemia perception, and cerebral function in insulin-dependent diabetes mellitus: evidence for an intrinsic effect of insulin on the central nervous system. J Clin Endocrinol Metab 1996, 81:1197-1205.
36. Davis SN, Colburn C, Dobbins R, Nadeau S, Neal D, Williams P, Cherrington AD: Evidence that the brain of the conscious dog is insulin sensitive. J Clin Invest 1995, 95:593-602.
37. Davis SN, Dunham B, Walmsley K, Shaveres C, Neal D, Williams P, Cherrington AD: Brain of the conscious dog is sensitive to physiological changes in circulating insulin. Am J Physiol 1997, 272:E567-E575.
38. Taborsky GJ Jr, Ahren B, Havel PJ: Autonomic mediation of glucagon secretion during hypoglycemia: implications for impaired A-cell responses in type 1 diabetes. Diabetes 1998, in press. An excellent review of the regulation of glucagon secretion and the role of the autonomic nervous system in hypoglycemia.
39. Havel PJ, Ahren B: Activation of autonomic nerves and the adrenal medulla contributes to increased glucagon secretion during moderate insulin-induced hypoglycemia in women. Diabetes 1997, 46:801-807.
40. Havel PJ, Valverde C: Autonomic mediation of glucagon secretion during insulin-induced hypoglycemia in rhesus monkeys. Diabetes 1996, 45:960-966.
41. Havel PJ, Mundinger TO, Taborsky GJ Jr: Pancreatic sympathetic nerves contribute to increased glucagon secretion during severe hypoglycemia in dogs. Am J Physiol 1996, 270:E20-E26.
42. Havel PJ, Parry SJ, Stern JS, Akpan JO, Gingerich RL, Taborsky GJ Jr, Curry DL: Redundant parasympathetic and sympathoadrenal mediation of increased glucagon secretion during insulin-induced hypoglycemia in conscious rats. Metab Clin Exp 1994, 43:860-866.
43. Kendall DM, Teuscher AU, Robertson RP: Defective glucagon secretion during sustained hypoglycemia following successful islet allo- and autotransplantation in humans. Diabetes 1997, 46:23-27.
44. Kendall DM, Rooney DP, Smets YFG, Salazar BL, Robertson RP: Pancreas transplantation restores epinephrine response and symptom recognition during hypoglycemia in patients with long-standing type I diabetes and autonomic neuropathy. Diabetes 1997, 46:249-257.
45. Frizzell RT, Jones EM, Davis SN, Biggers DW, Myers SR, Connolly CC, Neal DW, Jaspan JB, Cherrington AD: Counterregulation during hypoglycemia is directed by widespread brain regions. Diabetes 1993, 42:1253-1261.
46. Borg MA, Sherwin RS, Borg WP, Tamborlane WV, Shulman GI: Local ventromedial hypothalamus glucose perfusion blocks counterregulation during systemic hypoglycemia in awake rats. J Clin Invest 1997, 99:361-365. One of three papers from this group that nicely demonstrate the crucial role of the hypothalamus in counterregulatory hormone responses to hypoglycemia.
47. Borg WP, Sherwin RS, During MJ, Borg MA, Shulman GI: Local ventromedial hypothalamus glucopenia triggers counterregulatory hormone release. Diabetes 1995, 44:180-184.
48. Borg WP, During MJ, Sherwin RS, Borg MA, Brines ML, Shulman GI: Ventromedial hypothalamic lesions in rats suppress counterregulatory responses to hypoglycemia. J Clin Invest 1994, 93:1677-1682.
49. Kumagai AK, Kang YS, Boado RJ, Pardridge WM: Upregulation of blood-brain barrier GLUT1 glucose transporter protein and mRNA in experimental chronic hypoglycemia. Diabetes 1995, 44:1399-1404.
50. Koranyi L, Bourey RE, James D, Mueckler M, Fiedorek GT Jr, Permutt MA: Glucose transporter gene expression in rat brain: pretranslational changes associated with chronic insulin-induced hypoglycemia, fasting, and diabetes. Mol Cell Neurosc 1991, 2:244-252.
51. Uehara Y, Nipper V, McCall AL: Chronic insulin hypoglycemia induces GLUT-3 protein in rat brain neurons. Am J Physiol 1997, 272:E716-E719. First demonstration that neurons specifically adapt their glucose transporters in response to hypoglycemia.
52. Jones PW, Borg WP, Borg MA, Boulware SD, McCarthy G, Silver D, Tamborlane WV, Sherwin RS: Resistance to neuroglycopenia: an adaptative response during intensive insulin treatment of diabetes. J Clin Endocrinol Metab 1997, 82:1713-1718.
53. Heller SR, Macdonald IA: The measurement of cognitive function during acute hypoglycaemia: experimental limitations and their effect on the study of hypoglycaemia unawareness. Diabet Med 1996, 13:607-615.
54. George E, Marques JL, Harris ND, Macdonald IA, Hardisty CA, Heller SR: Preservation of physiological responses to hypoglycemia 2 days after antecedent hypoglycemia in patients with IDDM. Diabetes Care 1997, 20:1228-1230.
55. George E, Harris N, Bedford C, Macdonald IA, Hardisty CA, Heller SR: Prolonged but partial impairment of the hypoglycaemic physiological response following short-term hypoglycaemia in normal subjects. Diabetologia 1995, 38:1183-1190.
56. McCall AL: IDDM, counterregulation, and the brain. Diabetes Care 1997, 20:1228-1230.
57. Debrah K, Sherwin RS, Murphy J, Kerr D: Effect of caffeine on recognition of and physiological responses to hypoglycaemia in insulin-dependent diabetes. Lancet 1996, 347:19-24.
58. Kerr D, Sherwin RS, Pavalkis F, Fayad PB, Sikorski L, Rife F, Tamborlane WV, During MJ: Effect of caffeine on the recognition of and responses to hypoglycemia in humans. Ann Intern Med 1993, 119:799-804.
59. Pampanelli S, Fanelli C, Lalli C, Ciofetta M, Sindaco PD, Lepore M, Modarelli F, Rambotti AM, Epifano L, Di Vincenzo A, et al.: Long-term intensive insulin therapy in IDDM: effects of HbA1c, risk for severe and mild hypoglycaemia, status of counterregulation and awareness of hypoglycaemia. Diabetologia 1996, 39:677-686.
60. Fanelli CG, Epifano L, Rambotti AM, Pampanelli S, Di Vincenzo A, Modarelli F, Lepore M, Annibale B, Ciofetta M, Bottini P, et al.: Meticulous prevention of hypoglycemia normalizes the glycemic thresholds and magnitude of most of neuroendocrine responses to, symptoms of, and cognitive function during hypoglycemia in intensively treated patients with short-term IDDM. Diabetes 1993, 42:1683-1689.
61. Dagogo-Jack S, Rattarasarn C, Cryer PE: Reversal of hypoglycemia unawareness, but not defective glucose counterregulation, in IDDM. Diabetes 1994, 43:1426-1434.
62. Lingenfelser T, Buettner U, Martin J, Tobis M, Renn W, Kaschel R, Jakober B: Improvement of impaired counterregulatory hormone response and symptom perception by short-term avoidance of hypoglycemia in IDDM. Diabetes Care 1995, 18:321-325.
63. Fanelli C, Pampanelli S, Lalli C, Del Sindaco P, Ciofetta M, Lepore M, Porcellati F, Bottini P, Di Vincenzo A, Brunetti P, Bolli GB: Long-term intensive therapy of IDDM patients with clinically overt autonomic neuropathy: effects on hypoglycemia awareness and counterregulation. Diabetes 1997, 46:1172-1181.
64. Anderson JH Jr, Brunelle RL, Koivisto VA, Pfutzner A, Trautmann ME, Vignati L, Dimarchi R: Reduction of postprandial hyperglycemic and frequency of hypoglycemia in IDDM patients on insulin-analog treatment: Multicenter Insulin Lispro Study Group. Diabetes 1997, 46:265-270.
65. Garg SK, Carmain JA, Braddy KC, Anderson JH, Vignati L, Jennings MK, Chase HP: Pre-meal insulin analogue insulin lispro vs humulin R insulin treatment in young subjects with type 1 diabetes. Diabet Med 1996, 13:47-52.
66. Pfutzner A, Kustner E, Forst T, Schulze-Schleppinghoff B, Trautmann ME, Haslbeck M, Schatz H, Beyer J: Intensive insulin therapy with insulin lispro in patients with type 1 diabetes reduces the frequency of hypoglycemic episodes. Exp Clin Endocrinol Diabetes 1996, 104:25-30.
67. Pampanelli S, Torlone E, Lalli C, Del Sindaco P, Ciofetta M, Lepre M, Bartocci L, Brunetti P, Bolli GB: Improved postprandial metabolic control after subcutaneous injection of a short-acting insulin analog in IDDM of short duration with residual pancreatic beta-cell function. Diabetes Care 1995, 18:1452-1459.
68. Cryer PE: Banting Lecture. Hypoglycaemia: the limiting factor in the management of IDDM. Diabetes 1994, 43:1378-1389.
69. George E, Bedford C, Peacey SR, Hardisty CA, Heller SR: Further evidence for a high incidence of nocturnal hypoglycaemia in IDDM: no effect of dose for dose transfer between human and porcine insulins. Diabet Med 1997, 14:442-448.
70. Kaufman FR, Devgan S: Use of uncooked cornstarch to avert nocturnal hypoglycemia in children and adolescents with type I diabetes. J Diabetes Complications 1996, 10:84-87.
71. Saleh TV, Cryer PE: Alanine and terbutaline in the prevention of nocturnal hypoglycemia in IDDM. Diabetes Care 1997, 20:1231-1236.
72. Queale WS, Seidler AJ, Brancati FL: Glycemic control and sliding scale insulin use in medical inpatients with diabetes mellitus. Arch Intern Med 1997, 157:545-552.
73. Davis SN, Shavers C, Mosqueda-Garcia R, Costa F: Effects of differing antecedent hypoglycemia on subsequent counterregulation in normal humans. Diabetes 1997, 48:1328-1335.